4/28/2016 12:34:55 PM - Rallying near its all-time high. Reported earnings +8% on +5% sales revenues for the Mar '16 quarter. Prior quarterly comparisons also had sub par sales revenues and earnings were not strong and steady above the +25% minimum guideline (C criteria).

7/27/2015 12:45:01 PM - Announced plans to buy SNL Financial for $2.2 Billion and violated its 50 DMA line with a volume-driven loss. Reported earnings +16% on +3% sales revenues for the Jun '15 quarter. Prior quarterly comparisons also had sub par sales revenues and earnings were not strong and steady above the +25% minimum guideline (C criteria).

7/10/2015 2:57:37 PM - Sputtering below its 50 DMA line. Reported earnings +25% on +6% sales revenues for the Mar '15 quarter, and prior quarterly comparisons were not strong and steady above the +25% minimum guideline (C criteria).

2/20/2015 12:55:20 PM - Perched at its 52-week high today following a spurt of volume-driven gains into new high territory. The 2/12/15 mid-day report cautioned members - "Reported earnings +22% on +7% sales revenues for the Dec '14 quarter, and prior quarterly comparisons were not strong and steady above the +25% minimum guideline (C criteria)."

2/12/2015 12:39:55 PM - Hitting a new 52-week high today while adding to a recent spurt of volume-driven gains into new high territory. Reported earnings +22% on +7% sales revenues for the Dec '14 quarter, and prior quarterly comparisons were not strong and steady above the +25% minimum guideline (C criteria).

1/14/2015 12:29:05 PM - Sputtering below its 50 DMA line today following a big volume-driven gain on the prior session. Last noted in the 11/19/14 mid-day report with caution - "Reported earnings +32% on +10% sales revenues for the Sep '14 quarter, but prior quarterly comparisons were below the +25% minimum guideline (C criteria)."

11/19/2014 12:36:53 PM - Pulling back today after recently wedging to new highs with gains lacking great volume conviction. Reported earnings +32% on +10% sales revenues for the Sep '14 quarter, but prior quarterly comparisons were below the +25% minimum guideline (C criteria).